Docoh
Loading...

VASO VASO

Vaso Corp. engages in the healthcare equipment and information technology industries. It operates through the following segments: Information Technology (IT), Professional Sales Service, and Equipment. The IT segment focuses on healthcare IT and managed network technology services. The Professional Sales Service segment involves in selling healthcare capital equipment. The Equipment segment comprises of designing, manufacturing, selling, and servicing proprietary medical devices. The company was founded by John C. K. Hui and William Cross in July 1987 and is headquartered in Plainview, NY.

Company profile

Ticker
VASO
Exchange
CEO
Jun Ma
Employees
Incorporated
Location
Fiscal year end
Former names
VASOMEDICAL INC, VASOMEDICAL, INC
SEC CIK
IRS number
112871434

VASO stock data

(
)

Calendar

4 Jun 21
24 Jun 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from VASO earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 9.43M 9.43M 9.43M 9.43M 9.43M 9.43M
Cash burn (monthly) (positive/no burn) (positive/no burn) 208.33K (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) n/a n/a 580.82K n/a n/a n/a
Cash remaining n/a n/a 8.85M n/a n/a n/a
Runway (months of cash) n/a n/a 42.5 n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
30 Dec 19 Jonathan P Newton Common stock Grant Aquire A No No 0 500,000 0 1,275,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

0.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2 1 +100.0%
Opened positions 1 1
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 2.05K 2K +2.3%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Sonora Investment Management 2K $0 0.0%
Captrust Financial Advisors 45 $0 NEW
Largest transactions
Shares Bought/sold Change
Captrust Financial Advisors 45 +45 NEW
Sonora Investment Management 2K 0 0.0%

Financial report summary

?
Competition
CanonLumenAT&THologicMckesson
Risks
  • The impact of the COVID-19 pandemic on our markets and financial condition is difficult to predict and manage.
  • Achieving profitable operations is dependent on several factors
  • We currently derive a significant amount of our revenue and operating income from our agreement with GEHC.
  • We face competition from other companies and technologies.
  • We depend on management and other key personnel.
  • We may not continue to receive necessary FDA clearances or approvals, which could hinder our ability to market and sell certain products.
  • We have foreign operations and are subject to the associated risks of doing business in foreign countries.
  • We depend on several suppliers for the supply of certain products.
  • We may not have adequate intellectual property protection.
  • The loss or violation of certain of our patents and trademarks could have a material adverse effect upon our business.
  • Our growth could suffer if the markets into which we sell products decline, do not grow as anticipated or experience cyclicality.
  • Technological change is difficult to predict and to manage.
  • We are subject to product liability claims and product recalls that may not be covered by insurance.
  • We do not know the effects of healthcare reform proposals.
  • The application of the "penny stock" rules could adversely affect the market price of our common stock and increase your transaction costs to sell those shares.
  • Our common stock is subject to price volatility.
  • We do not intend to pay dividends in the foreseeable future.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: assurance, Bulletin, Codification, codified, connection, correct, desired, Error, light, misappropriation, opposed, participation, proforma, SAB, supervision, unchanged
Removed: acquisition, bearing, evaluated, February, Genwell, located, maturing, physiological, private, shareholder, Unsecured, Wuxi, Yuan